BackAcorda Therapeutics Overview

Acorda Therapeutics Current Cash

Track Acorda Therapeutics's current cash ($9.4M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$9.36M
↓ 69.05% YoYΔ $-20.89M vs prior year quarter

Peer average / median

Loading

Acorda Therapeutics Current Cash History

Loading

Acorda Therapeutics vs. peers: Current Cash Comparison

Loading

Acorda Therapeutics Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Acorda Therapeutics (ACOR) FAQ

Acorda Therapeutics (ACOR) currently reports a current cash of $9.4M as of March 2024. That compares with $30M in the prior-year period — down 69.0% year over year. Use the charts on this page to explore Acorda Therapeutics's current cash history and peer comparisons.

Acorda Therapeutics's current cash decreased from $30M to $9.4M — a 69.0% year-over-year decrease (period ending March 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Acorda Therapeutics reported $9.4M in current cash as of March 2024. That compares with $30M in the prior-year period — down 69.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $9.4M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Acorda Therapeutics, and consider following ACOR for alerts when major investors trade the stock.

Acorda Therapeutics is classified in the Healthcare sector. On current cash, it currently shows $9.4M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ACOR with unrelated industries.